Experienced in Benign Autosomal Dominant Myopathy

Robert D. Pitceathly

UCL Queen Square Institute Of Neurology
London, ENG, GB 
Experienced in Benign Autosomal Dominant Myopathy
UCL Queen Square Institute Of Neurology
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Robert Pitceathly practices in London, United Kingdom. Mr. Pitceathly is rated as an Experienced expert by MediFind in the treatment of Benign Autosomal Dominant Myopathy. His top areas of expertise are MELAS Syndrome, Progressive External Ophthalmoplegia, Mitochondrial Complex V Deficiency, and Myoglobinuria Recurrent.

His clinical research consists of co-authoring 106 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Benign Autosomal Dominant Myopathy.

Gender
Male

Locations

UCL Queen Square Institute of Neurology
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Drug
Study Drug: REN001
Study Phase: Phase 2

106 Total Publications

Biallelic NSUN3 Variants Cause Diverse Phenotypic Spectrum Disease: From Isolated Optic Atrophy to Severe Early-Onset Mitochondrial Disorder.
Biallelic NSUN3 Variants Cause Diverse Phenotypic Spectrum Disease: From Isolated Optic Atrophy to Severe Early-Onset Mitochondrial Disorder.
Journal: Investigative ophthalmology & visual science
Published: June 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pitceathly's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile